Physician profile
Darshan Patel
NPI 1962662957
$1,576.09
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,032 · 2020: $130 · 2021: $247 · 2022: $146 · 2023: $21.33.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $21.33.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $21.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $394.02 | 2019-2022 | |
| Allergan, INC. | $380.16 | 2019-2020 | |
| Edwards Lifesciences Corporation | $157.14 | 2019-2021 | |
| Chiesi USA, INC. | $141.45 | 2021 | |
| Alkermes, INC. | $137.97 | 2019 | |
| Gilead Sciences, INC. | $125.00 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $97.22 | 2019 | |
| Neurocrine Biosciences, INC. | $73.69 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $48.11 | 2019-2021 | |
| Daiichi Sankyo INC. | $21.33 | 2023 | Enhertu |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darshan Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.